Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aptevo Therapeutics (APVO) Tax Rate (2016 - 2019)

Aptevo Therapeutics' Tax Rate history spans 4 years, with the latest figure at 8.27% for Q3 2019.

  • For Q3 2019, Tax Rate changed N/A year-over-year to 8.27%; the TTM value through Sep 2019 reached 26.39%, changed N/A, while the annual FY2017 figure was 22.84%, 39381716.0% down from the prior year.
  • Tax Rate for Q3 2019 was 8.27% at Aptevo Therapeutics, up from 16.23% in the prior quarter.
  • Across five years, Tax Rate topped out at 127.67% in Q3 2017 and bottomed at 16.23% in Q4 2017.
  • The 4-year median for Tax Rate is 3.29% (2015), against an average of 11.91%.
  • The largest YoY upside for Tax Rate was 12766bps in 2017 against a maximum downside of -2360bps in 2017.
  • A 4-year view of Tax Rate shows it stood at 4.06% in 2015, then soared by 282bps to 7.37% in 2016, then crashed by -320bps to 16.23% in 2017, then skyrocketed by 151bps to 8.27% in 2019.
  • Per Business Quant, the three most recent readings for APVO's Tax Rate are 8.27% (Q3 2019), 16.23% (Q4 2017), and 127.67% (Q3 2017).